Acorah Software Products - Accounts Production 19.2.450 false true 30 September 2024 1 October 2023 false 1 October 2024 30 September 2025 30 September 2025 12849719 Dr Vanessa Theis Dr John Murray iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12849719 2024-09-30 12849719 2025-09-30 12849719 2024-10-01 2025-09-30 12849719 frs-core:CurrentFinancialInstruments 2025-09-30 12849719 frs-core:ShareCapital 2025-09-30 12849719 frs-core:RetainedEarningsAccumulatedLosses 2025-09-30 12849719 frs-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 12849719 frs-bus:FilletedAccounts 2024-10-01 2025-09-30 12849719 frs-bus:SmallEntities 2024-10-01 2025-09-30 12849719 frs-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 12849719 frs-bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 12849719 frs-bus:Director1 2024-10-01 2025-09-30 12849719 frs-bus:Director2 2024-10-01 2025-09-30 12849719 frs-countries:EnglandWales 2024-10-01 2025-09-30 12849719 2023-09-30 12849719 2024-09-30 12849719 2023-10-01 2024-09-30 12849719 frs-core:CurrentFinancialInstruments 2024-09-30 12849719 frs-core:ShareCapital 2024-09-30 12849719 frs-core:RetainedEarningsAccumulatedLosses 2024-09-30
Registered number: 12849719
Auey Medicines Limited
Financial Statements
For The Year Ended 30 September 2025
The PHLT Group
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 12849719
2025 2024
Notes £ £ £ £
Creditors: Amounts Falling Due Within One Year 4 (13,653 ) (13,653 )
NET CURRENT ASSETS (LIABILITIES) (13,653 ) (13,653 )
TOTAL ASSETS LESS CURRENT LIABILITIES (13,653 ) (13,653 )
NET LIABILITIES (13,653 ) (13,653 )
CAPITAL AND RESERVES
Called up share capital 5 1 1
Profit and Loss Account (13,654 ) (13,654 )
SHAREHOLDERS' FUNDS (13,653) (13,653)
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr Vanessa Theis
Director
26/06/2026
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Auey Medicines Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12849719 . The registered office is 10 Brookfield Road, Lymm, WA13 0QJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Research & development
Expenditure on research and development is currently being written off as it is incurred.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2024: 2)
2 2
4. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Other creditors 13,653 13,653
Page 2